PN

The Pennant Group, Inc.

PNTGHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$947.7M
+36.3% YoY
Net Income
$29.6M
+31.1% YoY
EBITDA
$60.8M
+36.9% YoY
Free Cash Flow
$2.7M

Scan Results

Daily timeframe
DateIndicatorDetails
Oct 15▲ MACD Positive CrossoverHistogram +0.0481, positive momentum
Oct 14▲ MACD Positive CrossoverHistogram +0.0085, positive momentum
About The Pennant Group, Inc.

The Pennant Group, Inc. provides healthcare services in the United States. The company carries a $1.46B market cap, placing it firmly in the small-cap category. It operates in two segments, Home Health and Hospice Services, and Senior Living Services.

Where PNTG stands vs its 150-day and 200-day moving averages

As of the October 15, 2026 close, PNTG finished 13.36% above its 150-day moving average ($36.01) and 17.81% above its 200-day moving average ($34.65). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is PNTG overbought or oversold?

At the October 15, 2026 close, PNTG's RSI(14) was 56.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.46B
P/E (TTM)46.02
Fwd P/E26.39
EPS$0.91
Beta1.25
52W Change+65.8%
Dividend Yield0.00%
ROE10.4%
Analysis

On the balance sheet, PNTG has $15.3M in cash with $495.6M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $2.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 10.4%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $439.7M (2021) to $947.7M (2025), reflecting a 116% increase over the period.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for The Pennant Group, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms